Donghong Deng

597 total citations
30 papers, 439 citations indexed

About

Donghong Deng is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Donghong Deng has authored 30 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Donghong Deng's work include Blood properties and coagulation (11 papers), Acute Myeloid Leukemia Research (9 papers) and Hemoglobinopathies and Related Disorders (6 papers). Donghong Deng is often cited by papers focused on Blood properties and coagulation (11 papers), Acute Myeloid Leukemia Research (9 papers) and Hemoglobinopathies and Related Disorders (6 papers). Donghong Deng collaborates with scholars based in China and United States. Donghong Deng's co-authors include Peng Cheng, Jie Yan, Lin Liao, Faquan Lin, Meiling Luo, Zhenfang Liu, Lulu Huang, Zengnan Mo, Peng Cheng and Jie Wei and has published in prestigious journals such as Medicine, Clinica Chimica Acta and Thrombosis Research.

In The Last Decade

Donghong Deng

29 papers receiving 436 citations

Peers

Donghong Deng
Snehal G. Thakkar United States
I Canavy France
Francis Donaldson United Kingdom
Marta Christov United States
Cyril Cyrus Saudi Arabia
Donghong Deng
Citations per year, relative to Donghong Deng Donghong Deng (= 1×) peers Tathagata Chatterjee

Countries citing papers authored by Donghong Deng

Since Specialization
Citations

This map shows the geographic impact of Donghong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghong Deng more than expected).

Fields of papers citing papers by Donghong Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donghong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghong Deng. The network helps show where Donghong Deng may publish in the future.

Co-authorship network of co-authors of Donghong Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Donghong Deng. A scholar is included among the top collaborators of Donghong Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donghong Deng. Donghong Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, D, Donghong Deng, & Biao Tang. (2025). Programmed Cell Death in Heart Failure: Mechanisms, Impacts, and Therapeutic Prospects. Reviews in Cardiovascular Medicine. 26(7). 38407–38407.
2.
Yan, Jie, Lin Liao, Donghong Deng, et al.. (2024). Guideline for diagnosis and management of congenital dysfibrinogenemia. Clinica Chimica Acta. 561. 119680–119680. 1 indexed citations
3.
Wei, Jie, Yan Huang, Mingyue Xiong, et al.. (2021). Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia. Annals of Translational Medicine. 9(17). 1386–1386. 23 indexed citations
4.
Wu, Yangyang, et al.. (2021). Congenital dysfibrinogenemia caused by γAla327Val mutation: structural abnormality of D region. Hematology. 26(1). 305–311. 1 indexed citations
5.
Shi, Lingling, Yan Huang, Weijie Zhou, et al.. (2020). Analyzing the key gene expression and prognostics values for acute myeloid leukemia. Translational Cancer Research. 9(11). 7284–7298. 12 indexed citations
6.
Huang, Yan, et al.. (2020). Comprehensively analyze the expression and prognostic role for ten-eleven translocations (TETs) in acute myeloid leukemia. Translational Cancer Research. 9(11). 7259–7283. 8 indexed citations
7.
Luo, Meiling, Jie Yan, Lin Liao, et al.. (2018). Abnormal fibrinogen with an Aα 16Arg → Cys substitution is associated with multiple cerebral infarctions. Journal of Thrombosis and Thrombolysis. 46(3). 409–419. 7 indexed citations
8.
Huang, Yulan, Yuan Long, Donghong Deng, et al.. (2018). Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin. Thrombosis Research. 172. 61–66. 17 indexed citations
9.
Zhou, Weijie, Meiling Luo, Jie Yan, et al.. (2018). A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys–Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia. Thrombosis Research. 172. 128–134. 5 indexed citations
10.
Wen, Jing, Hongying Li, Cheng Peng, et al.. (2017). Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome. International Journal of Hematology. 105(6). 777–783. 18 indexed citations
11.
Luo, Meiling, Donghong Deng, Peng Cheng, et al.. (2016). Three cases of congenital dysfibrinogenemia in unrelated Chinese families. Medicine. 95(39). e4864–e4864. 94 indexed citations
13.
Yan, Jie, Meiling Luo, Peng Cheng, et al.. (2016). A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release. International Journal of Hematology. 105(4). 506–514. 8 indexed citations
14.
Yan, Jie, Donghong Deng, Meiling Luo, et al.. (2015). Dysfibrinogenemia in a patient undergoing artificial abortion after misdiagnosis and review of the literature. Clinica Chimica Acta. 447. 86–89. 11 indexed citations
15.
Huang, Lulu, Donghong Deng, Qiang Xiao, et al.. (2015). Polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) are associated with susceptibility to adult acute myeloid leukemia in a Chinese population. Cancer Epidemiology. 39(3). 328–333. 9 indexed citations
16.
Huang, Ying, Donghong Deng, Hongying Li, et al.. (2015). Fas-670A>G polymorphism is not associated with an increased risk of acute myeloid leukemia development. Biomedical Reports. 4(2). 153–160. 3 indexed citations
17.
Xiao, Qiang, Donghong Deng, Hongying Li, et al.. (2014). GSTT1 and GSTM1 polymorphisms predict treatment outcome for acute myeloid leukemia: a systematic review and meta-analysis. Annals of Hematology. 93(8). 1381–1390. 16 indexed citations
19.
Liang, Yuzhen, Yongrong Lai, Paul Schwarzenberger, et al.. (2010). Targeted Agents for Chronic Myelogenous Leukemia: Will That Be the End of Allogeneic Bone Marrow Transplantation for That Disease?. Biology of Blood and Marrow Transplantation. 16(6). 848–853. 1 indexed citations
20.
Lai, Yongrong, Jie Ma, Paul Schwarzenberger, et al.. (2008). Combination of CsA, MTX and low-dose, short-course mycophenolate mofetil for GVHD prophylaxis. Bone Marrow Transplantation. 43(1). 61–67. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026